TransCode Therapeutics is selling 10 million shares of its common stock for 30 cents each. This has it expecting to raise gross proceeds of $30 million from the public offering of RNAZ stock.

Fintel reports that on August 15, 2023, HC Wainwright & Co. reiterated coverage of TransCode Therapeutics (NASDAQ:RNAZ) with a Buy recommendation. As of August 2, 2023, the average one-year price ...

BOSTON, April 26, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a leading clinical-stage oncology company committed to using its proprietary platform delivery system to ...

TransCode Therapeutics shares are trading lower by 16% during Monday's session. The company announced a 1-for-33 reverse stock split. Unlock your all-in-one trading dashboard with real-time alerts ...

You can copy an image and paste it as a PNG file. And soon you’ll also be able to use Advanced Paste to transcode media files. A forthcoming update to PowerToys will add media transcoding ...

TransCode Therapeutics (NASDAQ:RNAZ) stock is taking a beating on Tuesday after the biopharmaceutical company announced the pricing for a public offering of its shares. TransCode Therapeutics is ...

TransCode Therapeutics (NASDAQ:RNAZ) stock is rallying higher on Wednesday after the company withdrew plans for a secondary offering. According to the company, it won’t pursue a plan to sell 12. ...